BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20408842)

  • 1. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
    McNeer JL; Nachman JB
    Br J Haematol; 2010 Jun; 149(5):638-52. PubMed ID: 20408842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
    Mitchell CD; Richards SM; Kinsey SE; Lilleyman J; Vora A; Eden TO;
    Br J Haematol; 2005 Jun; 129(6):734-45. PubMed ID: 15952999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
    Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
    Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent steroid therapy increases severity of varicella infections in children with acute lymphoblastic leukemia.
    Hill G; Chauvenet AR; Lovato J; McLean TW
    Pediatrics; 2005 Oct; 116(4):e525-9. PubMed ID: 16199681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
    Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid withdrawal syndrome during steroid tapering in childhood acute lymphoblastic leukemia: a controlled study comparing prednisone versus dexamethasone in induction phase.
    Saracco P; Bertorello N; Farinasso L; Einaudi S; Barisone E; Altare F; Corrias A; Pastore G
    J Pediatr Hematol Oncol; 2005 Mar; 27(3):141-4. PubMed ID: 15750445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid-induced glaucoma in children with acute lymphoblastic leukemia: a possible complication.
    Yamashita T; Kodama Y; Tanaka M; Yamakiri K; Kawano Y; Sakamoto T
    J Glaucoma; 2010 Mar; 19(3):188-90. PubMed ID: 19661822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
    Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
    Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
    Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
    Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
    Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
    Ularntinon S; Tzuang D; Dahl G; Shaw RJ
    Pediatrics; 2010 May; 125(5):e1241-5. PubMed ID: 20385646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Bostrom BC; Sensel MR; Sather HN; Gaynon PS; La MK; Johnston K; Erdmann GR; Gold S; Heerema NA; Hutchinson RJ; Provisor AJ; Trigg ME;
    Blood; 2003 May; 101(10):3809-17. PubMed ID: 12531809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious toxicity of dexamethasone during all remission-induction chemotherapy: report of two cases and literature review.
    Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
    Pediatr Hematol Oncol; 2004; 21(1):27-35. PubMed ID: 14660304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of recovery of adrenal function in children treated for leukemia.
    Felner EI; Thompson MT; Ratliff AF; White PC; Dickson BA
    J Pediatr; 2000 Jul; 137(1):21-4. PubMed ID: 10891816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
    Marino S; Verzegnassi F; Tamaro P; Stocco G; Bartoli F; Decorti G; Rabusin M
    Pediatr Blood Cancer; 2009 Dec; 53(6):984-91. PubMed ID: 19621425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
    Te Poele EM; de Bont ES; Marike Boezen H; Revesz T; Bökkerink JP; Beishuizen A; Nijhuis IJ; Oude Nijhuis CS; Veerman AJ; Kamps WA
    Eur J Cancer; 2007 Nov; 43(17):2532-6. PubMed ID: 17702568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of dexamethasone before remission induction, in de novo childhood acute lymphoblastic leukemia.
    López-Hernández MA; Alvarado M; De Diego J; Borbolla-Escoboza JR; Jiménez RM; Trueba E
    Haematologica; 2004 Mar; 89(3):365-6. PubMed ID: 15020281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
    Tolar J; Bostrom BC; La MK; Sather HN
    Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.